Cluster-randomized trials

Peter Fayers, M. S. Jordhøy, S. Kaasa

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Randomized clinical trials have become a major tool in the process of evaluating the benefits of new treatments or other interventions. One principal reason for this is that well-designed randomized trials can avoid the problems of bias, which might arise due to patient selection. The issues concerning these trials are largely cluster-randomized trials have become increasingly common, in both palliative medicine and diverse other health research areas. Cluster-randomized trials are characterized by the randomization of groups -clusters - of patients rather than individuals, and may offer many major advantages but also involve several particular considerations.
Original languageEnglish
Pages (from-to)69-70
Number of pages2
JournalPalliative Medicine
Volume16
Issue number1
DOIs
Publication statusPublished - 1 Jan 2002

Cite this

Cluster-randomized trials. / Fayers, Peter; Jordhøy, M. S.; Kaasa, S.

In: Palliative Medicine, Vol. 16, No. 1, 01.01.2002, p. 69-70.

Research output: Contribution to journalArticle

Fayers, P, Jordhøy, MS & Kaasa, S 2002, 'Cluster-randomized trials', Palliative Medicine, vol. 16, no. 1, pp. 69-70. https://doi.org/10.1191/0269216302pm503xx
Fayers, Peter ; Jordhøy, M. S. ; Kaasa, S. / Cluster-randomized trials. In: Palliative Medicine. 2002 ; Vol. 16, No. 1. pp. 69-70.
@article{d150ac35d18244c48046a9097c73f81a,
title = "Cluster-randomized trials",
abstract = "Randomized clinical trials have become a major tool in the process of evaluating the benefits of new treatments or other interventions. One principal reason for this is that well-designed randomized trials can avoid the problems of bias, which might arise due to patient selection. The issues concerning these trials are largely cluster-randomized trials have become increasingly common, in both palliative medicine and diverse other health research areas. Cluster-randomized trials are characterized by the randomization of groups -clusters - of patients rather than individuals, and may offer many major advantages but also involve several particular considerations.",
author = "Peter Fayers and Jordh{\o}y, {M. S.} and S. Kaasa",
year = "2002",
month = "1",
day = "1",
doi = "10.1191/0269216302pm503xx",
language = "English",
volume = "16",
pages = "69--70",
journal = "Palliative Medicine",
issn = "0269-2163",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Cluster-randomized trials

AU - Fayers, Peter

AU - Jordhøy, M. S.

AU - Kaasa, S.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Randomized clinical trials have become a major tool in the process of evaluating the benefits of new treatments or other interventions. One principal reason for this is that well-designed randomized trials can avoid the problems of bias, which might arise due to patient selection. The issues concerning these trials are largely cluster-randomized trials have become increasingly common, in both palliative medicine and diverse other health research areas. Cluster-randomized trials are characterized by the randomization of groups -clusters - of patients rather than individuals, and may offer many major advantages but also involve several particular considerations.

AB - Randomized clinical trials have become a major tool in the process of evaluating the benefits of new treatments or other interventions. One principal reason for this is that well-designed randomized trials can avoid the problems of bias, which might arise due to patient selection. The issues concerning these trials are largely cluster-randomized trials have become increasingly common, in both palliative medicine and diverse other health research areas. Cluster-randomized trials are characterized by the randomization of groups -clusters - of patients rather than individuals, and may offer many major advantages but also involve several particular considerations.

U2 - 10.1191/0269216302pm503xx

DO - 10.1191/0269216302pm503xx

M3 - Article

VL - 16

SP - 69

EP - 70

JO - Palliative Medicine

JF - Palliative Medicine

SN - 0269-2163

IS - 1

ER -